(Q40612594)

22 September 2017

title

IFNgamma sensitization to TRAIL-induced apoptosis in human thyroid carcinoma cells by upregulating Bak expression (English)

1 reference

22 September 2017

1 reference

Su He Wang

1

1 reference

22 September 2017

Emese Mezosi

2

1 reference

22 September 2017

Julie M Wolf

3

1 reference

22 September 2017

Zhengyi Cao

4

1 reference

22 September 2017

Saho Utsugi

5

1 reference

22 September 2017

Paul G Gauger

6

1 reference

22 September 2017

Gerard M Doherty

7

1 reference

22 September 2017

James R Baker

8

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

22 September 2017

1 reference

22 September 2017

volume

23

1 reference

22 September 2017

issue

4

1 reference

22 September 2017

page(s)

928-935

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207213

22 September 2017

exact match

0 references

cites work

Clinical review 158: Beyond radioiodine: a review of potential new therapeutic approaches for thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Differential human multiple myeloma cell line responsiveness to interferon-alpha. Analysis of transcription factor activation and interleukin 6 receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Molecular cross-talk between the TRAIL and interferon signaling pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

The Bcl-2 family and cell death regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Interferon-gamma modulates a p53-independent apoptotic pathway and apoptosis-related gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Effect of interferon-gamma on the susceptibility to Fas (CD95/APO-1)-mediated cell death in human hepatoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Tumor necrosis factor-alpha induces Bax-Bak interaction and apoptosis, which is inhibited by adenovirus E1B 19K

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

Anaplastic thyroid carcinoma: behavior, biology, and therapeutic approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

TRAIL death pathway expression and induction in thyroid follicular cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Administration of interferon-gamma in healthy subjects does not modulate thyroid hormone metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

IFNgamma sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

The receptor for the cytotoxic ligand TRAIL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Bak can accelerate chemotherapy-induced cell death independently of its heterodimerization with Bcl-XL and Bcl-2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

1Alpha,25-dihydroxyvitamin D3 up-regulates Bcl-2 expression and protects normal human thyrocytes from programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Susceptibility of thyroid cancer cells to 7-hydroxystaurosporine-induced apoptosis correlates with Bcl-2 protein level

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207213

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207213

1 reference

Dimensions Publication ID

22 September 2017

1031923734

0 references

1 reference